@article{girot:hal-02648813, TITLE = {{Short article: Evaluation of O6-methylguanine-DNA methyltransferase as a predicting factor of response to temozolomide-based chemotherapy in well-differentiated metastatic pancreatic neuroendocrine tumors}}, AUTHOR = {Girot, Paul and Dumars, Clotilde and Mosnier, Jean-Fran{\c c}ois and Muzellec, L{\'e}a and Senellart, H{\'e}l{\`e}ne and Foubert, Fanny and Caroli-Bosc, Fran{\c c}ois-Xavier and Cauchin, Estelle and R{\'e}genet, Nicolas and Matysiak-Budnik, Tamara and Touchefeu, Yann}, URL = {https://univ-angers.hal.science/hal-02648813}, JOURNAL = {{European Journal of Gastroenterology \& Hepatology}}, PUBLISHER = {{Lippincott, Williams \& Wilkins}}, VOLUME = {29}, NUMBER = {7}, PAGES = {826-830}, YEAR = {2017}, DOI = {10.1097/MEG.0000000000000874}, KEYWORDS = {Predictive Value of Tests ; Promoter Regions ; Genetic ; Retrospective Studies ; Temozolomide ; Time Factors ; Treatment Outcome ; Tumor Suppressor Proteins ; Adult ; Aged ; 80 and over ; Antineoplastic Combined Chemotherapy Protocols ; Biomarkers ; Tumor ; Cell Differentiation ; Dacarbazine ; Disease Progression ; Disease-Free Survival ; DNA Methylation ; DNA Modification Methylases ; DNA Repair Enzymes ; Female ; France ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neuroendocrine Tumors ; Pancreatic Neoplasms ; Patient Selection ; Polymerase Chain Reaction ; Precision Medicine}, HAL_ID = {hal-02648813}, HAL_VERSION = {v1}, }